# FDA recall D-0065-2023

> **Nephron Sterile Compounding Center LLC** · Class II · drug recall initiated 2022-11-10.

## Product

PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2.

## Reason for recall

CGMP Deviations: Potential for cross contamination due to product carry over.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0065-2023
- **Recalling firm:** Nephron Sterile Compounding Center LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-11-10
- **Report date:** 2022-11-23
- **Termination date:** 2024-09-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** West Columbia, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0065-2023

## Citation

> AI Analytics. FDA recall D-0065-2023. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0065-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*